HEALTHglobal
STAT+: J&J wins approval for first-of-its-kind psoriasis pill
Single source
Updated 3 hours ago
First seen March 19, 2026 04:15:48Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Johnson & Johnson won U.S. approval for a daily psoriasis pill that rivals the benefits of injectable medicines and could roil a multibillion-dollar market.